REG - Cambridge Cognition - Grant of Options <Origin Href="QuoteRef">COGC.L</Origin>

Cambridge Cognition HoldingsAnnouncement

02/11/2017 07:06

RNS Number : 2556V
Cambridge Cognition Holdings PLC
02 November 2017
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Grant of Options
The neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets software products to improve brain health, announces that on 1st November 2017, the Company granted options ("Options") over a total of 50,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's EMI option scheme to a Person Discharging Managerial Responsibilities ("PDMR") on behalf of the Company.
The 50,000 Options granted to the PDMR are exercisable at a price of 1 pence per Ordinary Share from three years following the date of award until the tenth anniversary of the date of award, subject to satisfying the following performance criteria:
- 55% of the Options granted will vest if the average closing mid-market price of an Ordinary Share for the final 10 trading days of 2018 is greater than 140 pence per Ordinary Share. A pro rata sliding scale will apply if the average closing mid-market price of an Ordinary Share for the final 10 trading days of 2018 is between 100 pence and 140 pence per Ordinary Share; and
- 45% of the Options granted will vest if the cumulative revenue of the Company reported in the audited accounts for the three financial years ended 31 December 2018 exceeds 23m.
Following the grant of Options, the total number of Options outstanding over unissued Ordinary Shares is 1,920,949, representing approximately 9.28% of the Company's issued share capital.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. 
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mark Miller-Holliday - Director of International Sales and Business Development
2. 
Reason for the Notification
a)
Position/status
See 1(a) above for position - classified as a PDMR of the Company
b)
Initial notification/ Amendment
Initial Notification
3. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cambridge Cognition Holdings Plc
b)
LEI
213800SZKDIN122EPA96
4. 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
The grant of Options over Ordinary Shares on 1 November 2017
Identification code
GB00B8DV9647
b)
Nature of the transaction
Grant of Options over Ordinary Shares
c)
Price(s) and volume(s)
Price: n/a
Volumes: Mark Miller-Holliday - 50,000 Options
d)
Aggregated information:
 Aggregated volume
 Price
n/a
e)
Date of the transaction
1 November 2017
f)
Place of the transaction
Outside a trading venue
Enquiries
Cambridge Cognition Holdings PLC

Steven Powell, Chief Executive Officer
Noah Konig, Director of Product Marketing and Communications
Tel: 01223 810 700
press@camcog.com


finnCap Ltd (NOMAD and Joint Broker)
Tel: 020 7220 0500
Geoff Nash / Simon Hicks
(Corporate Finance)
Alice Lane
(Corporate Broking)
Dowgate Capital Stockbrokers Limited (Joint Broker)
David Poutney/ James Serjeant
Tel: 020 3903 7715
(Corporate Broking)


IFC Advisory Limited (Financial PR and IR)
Tel: 020 3053 8671
Tim Metcalfe/ Graham Herring


This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBFLFBDFFZFBV